| 000 | 00937 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517144657.0 | ||
| 264 | 0 | _c20180226 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1468-3288 | ||
| 024 | 7 |
_a10.1136/gutjnl-2017-313869 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaurain, Anne | |
| 245 | 0 | 0 |
_aMortality associated with the treatment of HCV with direct-acting antivirals. _h[electronic resource] |
| 260 |
_bGut _c01 2018 |
||
| 300 |
_a197-198 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAntiviral Agents |
| 650 | 0 | 4 | _aHepatitis C, Chronic |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aKramer, Laura | |
| 700 | 1 | _aSultanik, Philippe | |
| 700 | 1 | _aVallet-Pichard, Anaïs | |
| 700 | 1 | _aSogni, Philippe | |
| 700 | 1 | _aPol, Stanislas | |
| 773 | 0 |
_tGut _gvol. 67 _gno. 1 _gp. 197-198 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gutjnl-2017-313869 _zAvailable from publisher's website |
| 999 |
_c27014806 _d27014806 |
||